Med-X, Inc. is in live offering mode and is actively accepting Title IV investments.
$420.00 minimum investment

Med-X, Inc.

A LEADER IN GREEN SOLUTIONS

Regulation A+
Canoga Park, CA
Pharmaceutical
Accepting International Investment

Invest in Med-X, Inc, a company that has raised over $7,000,000 from over 2,400 investors to date on StartEngine.

To create a better world for future generations we have to change. Chemicals from large conglomerates are adversely impacting the health of ourselves, our communities and the planet. As a group, we must come together and fight for a greener future. Today we ask you to join our mission to protect our families from the unnecessary dangers associated with short and long-term exposure to synthetic chemicals. Together we can bring forth a brighter and healthier future free of the toxic poisons we use in our homes and bodies every day, while simultaneously allowing our shareholders to prosper from the company’s growth and liquidity goals.


View our offering circular

A LEADER IN GREEN SOLUTIONS

The company is now raising $10M in the second round of Regulation A+ crowdfunding to support the growth of its portfolio of brands, develop new exciting products and pursue acquisition opportunities.  All of this will provide our customers with safe and effective solutions to products and services that historically overuse toxic synthetic chemicals and addictive pharmaceutical products.

THE PROBLEM

Nearly everyone on this planet is exposed to pesticides or has taken a pain relief pill. And science has proven the long-term health complications and diseases that can happen as a result.  Yet, too few people are aware that alternative, Eco-friendly products, and methods exist in the market that does the similar job, with the same efficacy, but with zero negative impact to oneself or the environment.


Reports estimate that in the United States alone over 20 billion pounds of pesticides have been sprayed on our properties and food in just the last 20 years. Globally in the same timespan, this industry has generated over $1 Trillion in revenues. So, why are we all so exposed?

Historically, the use of synthetic chemicals in all of our food, drugs, products, and industries has been controlled by a small group of very large and powerful international corporations. These corporations hold patents and spend millions of dollars lobbying governments all over the world to make sure their products are deemed safe for use, even though the long-term effects from exposure have been proven to be unhealthful and dangerous.. 


Most of these synthetic chemicals contain strong toxic/poisonous chemicals with proven long-lasting, devastating carcinogenic effects. These compounds can take generations to become nascent in the environment. As more chemicals are sprayed or used in products, the build-up just keeps compounding the pollution that harms the environment. 

146 Million Americans were Prescribed Opioids in 2017

We all know a family that has been impacted by the Opioid Public Health crisis the Pharmaceutical conglomerates have directly caused in this country by using similar unethical tactics of lobbying to get their addictive drugs in the hands of as many everyday Americans as possible. These addictive drugs that have been marketed for the use of everyday pain when science clearly proves the addictive nature of the chemicals used to make them. For a person born in 2017 the odds of dying from an Opioid Overdose is now higher than dying in a car accident.

Over 1 Billion Pounds of Pesticides are used in the United State each year

Chemicals from plastics and pesticides are now beginning to be found in our groundwater and public drinking water supplies for the first time. No wonder numerous studies are now linking diseases such as Parkinson’s disease, asthma, cancer and reproductive dysfunction to chemical pesticides.

THE MED-X SOLUTION

Med-X, Inc. has developed multiple all-natural plant-based brands of products that solve the same everyday issues people have been using chemicals to solve. Med-X is able to sell these products into the homes of everyday Americans through our partnerships with major retail and healthcare distributors as well as the leading international professional pest control distributors. The company is constantly marketing and educating the public about the dangers we face while at the same time offering real, proven effective, safe solutions. Through targeted marketing, national and international distribution venues and exposure through our media divisions, our high margin proprietary products are cutting through the noise and getting mainstream attention and sell-through. Med-X is also on the cutting edge of green product development by introducing new cannabis/hemp topical and supplement products that will also become available to consumers in the future.


We would love to tell you that our green solution products and services will bring down big chemical and big pharma., but let’s be real, that is not going to happen. The point of this mission, in fact, is more about balance, transparency, and responsibility. Our goal here is to simply offer alternatives in markets that frankly have never embraced safe and effective natural options and as you are aware, our thinking and products are beginning to resonate.

We are at the forefront of providing safer alternatives to big chemical and big pharma which will allow them to become more accountable. The consumer is demanding it. Times have changed. If you can offer a person two solutions to a problem, one is a chemical solution and one is a green solution, most Americans will now choose the green option as long as it has similar results. It is proven most Americans will actually pay substantially more for a safer option. Thankfully the products Med-X produces, fall in line with middle America value and the company has sourced product ingredients and have focused on low-cost manufacturing techniques that enable the company to offer these products at favorable costs to consumers while holding higher margins for stakeholders.


In the past, there were little or no options for a homeowner to choose an effective green pesticide to be used in their home. Likewise, there were limited safe, drug-free options for truly relieving a migraine headache or everyday chronic pain. Now there are multiple options being offered by our Med-X Divisions and more that are in final development by Med-X scientists, doctors, and formulators. These products are proven effective in clinical trials and many are already in national and international distribution channels with sell-through driving growth.

Making a Difference, One Community at a Time.

Med-X, Inc. is an innovator and leader in developing all-natural and alternative solutions to the outdated poisonous chemicals and harmful pharmaceutical products, often used in pest control and pain management. Med-X incorporates best-in-class science, research and technology for manufacturing and service capabilities across pest control, pain management, aromatherapy, by primarily utilizing essential oil product development. 


The company’s sales are represented by multiple commercial sales verticals and third-party service providers managed through various domestic and international distribution partners. Retail sales are currently conducted by over-the-counter pharmacy retailers and various e-commerce service providers. Med-X, Inc. is also focused on educating the public by supporting its digital media platforms of The Marijuana Times and The National Investor Network.

Med-X, Inc. has built a portfolio of high margin commercial and consumer product brands as well as pest control services. These proven brands help drive the company’s current revenue. This portfolio strategy gives the company flexibility and power to scale up operations, and raise revenues in any sector by acquiring other like-minded brands who fit the company mission and would like the opportunity to grow together. The company is already in talks with several small to medium-sized companies who have shown interest in being a part of a bigger green movement.


The Med-X management team is motivated to continue to grow revenue and raise the capital needed to take the company public on a national exchange. Med-X has reserved the Nasdaq ticker symbol, (MXRX) and plans to offer its investors liquidity by entering the public market in the future.

Nature-Cide

The entire Nature-Cide line of products has 10 years of research and development behind them. All of these products have been proven effective in the field by licensed pest management professionals as well as by conducting third party laboratory efficacy tests. These products are currently being utilized for major commercial and residential use worldwide in pest control, hospitality, janitorial, transportation and agriculture (Including cannabis cultivation). Nature-Cide is available to Pest Management Professionals through nationwide distribution such as Target Specialty Products, Residex, Univar, PCS and more!

Thermal-Aid

Thermal-Aid all-natural products are clinically proven and patented therapeutic heating/cooling modality designed explicitly for the medical field, to reduce swelling and relieve various pain issues. Thermal-Aid products cover a wide variety of needs for patients in all age groups for a gamut of ailments including but not limited to arthritis, fibromyalgia, multiple sclerosis, migraines, back pain, and muscle aches. Thermal-Aid products can be found in various OTC pharmacy outlets and qualify for patient insurance reimbursement and FSA programs throughout the United States.

Malibu Brands

Malibu Brands is a premium, homeopathic lifestyle brand.  Malibu Brands' first product is the Pacific Pain Relief Cream, which is a proven, natural topical analgesic cream for the temporary relief of various pains including arthritis, joint, muscle, headache, and migraine pain. Malibu Brands is working to expand its product footprint with multiple products in development including a pain cream that utilizes as an ingredient. Additionally, the Malibu Brands division is planning to embark on designing a unique clothing line that uses alternative sustainable materials such as hemp fiber and bamboo as they become readily available.

The Marijuana Times

The Marijuana Times is a thought leader in the cannabis space, especially with exposing certain blemished areas of the industry, such as the widespread unregulated chemical use by cultivators and the dangerous health impact of consuming products with high levels of synthetic chemicals. The Marijuana Times publishes content on a daily basis via its a website, IOS news application, audio podcast and daily Youtube news show. The publication is a verified Google News and Apple News, publisher.


National Investor Network

The National Investor Network is a hub for everyday investors to gather resources and information in regards to companies raising capital using public or private equity.  It serves as a portal with an extensive information base of companies and executives who are publicly raising capital or trading securities. This venue will be positioned to assist Med-X and other private and public companies with information dissemination to assist in their pursuits.

GOING FORWARD STRATEGY

Nature-Cide Products & Services

Expand market positioning with commercial advertising and expanded distribution of the Nature-Cide product lines for continued sale in Commercial Pest Control, Hospitality, Janitorial, Transportation, Housing Authorities, School Districts, Turf-Care and Agriculture including cannabis cultivation. We will also be preparing several Nature-Cide Ready to Use SKUs for consumer use to be primarily positioned in various Big Box retail.

The Nature-Cide service division plans to continue to grow it’s footprint in the Greater Los Angeles area as the management team continues to aggressively push to increase revenues and market share by acquiring existing pest control service companies and injecting the Nature-Cide products and IPM model into their existing book of business.

Thermal-Aid and Malibu Brands Products

Expand market presence of Thermal-Aid in Pain Management sectors including insurance coverage segments for Physical Therapy, Flexible Spending, and Patient Care while continuing the expansion of its retail footprint within the OTC Pharmacy space. Continue the placement of all products that fit within consumer retail with e-commerce expansion, including positioning the Malibu Brands assortment of products into the same position.

PRODUCT POSITIONING

NATIONAL PEST CONTROL AND HEALTHCARE DISTRIBUTION

Nature-Cide is being used by a growing network of commercial customers including licensed pest control companies, like the nationally positioned PestMaster Services, which provides peat control services in fourteen states. Nature-Cide currently supplies Univar Solutions, Target Specialty Products and its parent company “Rentokil Initial” in various regions including Asia and India.  The Company plans to continue aggressively marketing within the Pest Control, Hospitality, Transportation, Agriculture, and Janitorial supply markets, while also pursuing implementation of Nature-Cide in state and federal facilities throughout various regions in the United States.

PEST MANAGEMENT MARKET OVERVIEW

The global insect pest control market is projected to grow from $12.4 billion in 2016 to $17.3 billion by 2022, according to research firm MarketsandMarkets. The insect pest control market is driven by government regulations on food hygiene, public health, environmental health, and growing public awareness. The need to improve service quality for customers is expected to provide an impetus for growth in innovative pest control solutions. Lack of skilled technicians and delayed regulatory approval process for chemical products in different applications (such as residential, commercial, and industrial areas) have been considered restraining factors for the market and offer opportunities for products that fall under the less regulated FIFRA 25(b) Minimum Risk Pesticide category.

PAIN MANAGEMENT MARKET OVERVIEW

The global pain management drug market is estimated to grow from $36.6 billion in 2014 to $44.3 billion by 2020.  Pain is a distressing sensory and emotional feeling, which occurs due to tissue damage or illness. Various diseases, such as multiple sclerosis, osteoarthritis, stomach ulcer, chronic arthritis, fibromyalgia, diabetic neuropathy, and cancer can cause pain. The duration of the pain varies from short-term known as acute pain to long-term referred to as chronic pain. Traditionally, the management of pain involves the reduction or treatment of pain using a particular set of drugs. Currently, 166 people die each day from an overdose by abusing prescription opiate pain medication. The need to improve service quality and safety for patients is expected to provide an impetus for growth in the pain management solution market.

CANNABIS PRODUCTS AND SERVICES

The Med-X, management team are major proponents of the legalization of medical cannabis on a federal level. As a member of the pest control community in the cannabis industry, the team hopes to expand its footprint in this emerging market by not only supplying pest control products to cannabis and hemp cultivators but also legally participating in the cultivation and manufacturing of Hemp and Cannabis products.

Company management holds licenses for various types of applications for Pest Control and is trained and proficient in several types of cultivation, including hemp and cannabis. Management is proficient in supercritical CO2 extraction of all types of essential oils, and if and when the Federal Government eases rules and regulations on hemp and medical cannabis cultivation, sales, manufacturing and transportation, the Company is positioned to enter cultivation and manufacturing of all types of hemp and medical cannabis-related products.

CANNABIS MARKET OVERVIEW

The legalization of recreational/medical cannabis is taking over the United States. Multiple states have seen massive tax gains from legalizing recreational use while medical system states continue to be a model for other states around the country. More than half of the states in the U.S. have some medical marijuana legislation.

UNITED STATES CANNABIS LEGALIZATION

EXPECTED REVENUES ARE TOO BIG TO IGNORE

As more states legalize medical and recreational cannabis, the demand for Med-X's quality products is growing. Innovation is where Med-X excels, and Med-X consumer-ready products support the expansion of the industry.


State by state, new requirements for contaminant testing and product potency are affecting cultivators who handle pests and molds with harmful and toxic treatments of the past. As laws remove harmful and poisonous pesticides from the cultivation facilities and require nontoxic treatments, Nature-Cide is positioned to become an industry standard for organic pest control management.

WHY INVEST?

TRACTION

GROWING REVENUE

DISTRIBUTION

HEMP & CANNABIS 

MAKE A DIFFERENCE

PORTFOLIO MODEL

IN-HOUSE MEDIA

PATH TO LIQUIDITY

There is a very large demand for new effective all-natural solutions in both mainstream pest control and in the world of pharmaceuticals. The potential for the investor to prosper in these markets is there. These markets are long overdue for new ideas and innovations and opportunities to invest in these markets is rare and difficult to come by for the working-class American.


An investment in Med-X, is the opportunity to get in on the ground floor of a company that is already disrupting these markets with green options. We know that a larger portion of the market shares in these industries has to move to the safer, greener side and we are sitting perfectly to address the needs of the markets as consumers continue to demand alternative options.

COMPANY TIMELINE

FREQUENTLY ASKED QUESTIONS

All Economic Value details, including future projections, employment numbers and or statistics, are sourced from The Marijuana Business Fact Book. Produced by the Marijuana Business Daily. Industry and revenue statistics are sourced from the ArcView Market Research Report.


What is Reg A+ Equity Crowdfunding?


In June 2015, the final Regulation A+ rules under Title IV of the JOBS Act of 2012 became effective, after approval by the Securities and Exchange Commission, paving the way for companies like Med-X, Inc. to raise up to $50 million from both accredited and non-accredited investors.


Med-X, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA).


THE SECURITIES OFFERED HEREBY ARE HIGHLY SPECULATIVE. INVESTING IN SHARES OF MED-X, INC. INVOLVES SIGNIFICANT RISKS.


THIS INVESTMENT IS SUITABLE ONLY FOR PERSONS WHO CAN AFFORD TO LOSE THEIR ENTIRE INVESTMENT. FURTHERMORE, INVESTORS MUST UNDERSTAND THAT THEIR INVESTMENT IN MED-X, INC. COULD BE ILLIQUID FOR AN INDEFINITE PERIOD OF TIME. NO PUBLIC MARKET CURRENTLY EXISTS FOR THE SECURITIES AND IF A PUBLIC MARKET DEVELOPS FOLLOWING THIS OFFERING IT MAY NOT CONTINUE.


MED-X, INC. 8236 REMMET AVENUE CANOGA PARK, CA 91304 - YOU SHOULD READ THE OFFERING CIRCULAR BEFORE MAKING ANY INVESTMENT.

VIEW OFFERING CIRCULAR HERE


THE OFFERING MATERIALS MAY CONTAIN FORWARD-LOOKING STATEMENTS AND INFORMATION RELATING TO, AMONG OTHER THINGS, MED-X, INC., ITS BUSINESS PLAN AND STRATEGY, AND ITS INDUSTRY. THESE FORWARD-LOOKING STATEMENTS ARE BASED ON THE BELIEFS OF, ASSUMPTIONS MADE BY, AND INFORMATION CURRENTLY AVAILABLE TO MED-X, INC.’S MANAGEMENT. WHEN USED IN THE OFFERING MATERIALS, THE WORDS “ESTIMATE,” “PROJECT,” “BELIEVE,” “ANTICIPATE,” “INTEND,” “EXPECT” AND SIMILAR EXPRESSIONS ARE INTENDED TO IDENTIFY FORWARD-LOOKING STATEMENTS, WHICH CONSTITUTE FORWARD LOOKING STATEMENTS. THESE STATEMENTS REFLECT MANAGEMENT’S CURRENT VIEWS WITH RESPECT TO FUTURE EVENTS AND ARE SUBJECT TO RISKS AND UNCERTAINTIES THAT COULD CAUSE THE COMPANY’S ACTUAL RESULTS TO DIFFER MATERIALLY FROM THOSE CONTAINED IN THE FORWARD-LOOKING STATEMENTS. INVESTORS ARE CAUTIONED NOT TO PLACE UNDUE RELIANCE ON THESE FORWARD-LOOKING STATEMENTS, WHICH SPEAK ONLY AS OF THE DATE ON WHICH THEY ARE MADE. MED-X, INC. DOES NOT UNDERTAKE ANY OBLIGATION TO REVISE OR UPDATE THESE FORWARD-LOOKING STATEMENTS TO REFLECT EVENTS OR CIRCUMSTANCES AFTER SUCH DATE OR TO REFLECT THE OCCURRENCE OF UNANTICIPATED EVENTS.

In the Press

Med-X, Inc. will not be Affected Adversely by Attorney General Jeff Sessions Rescission of the Cole Memo
January 5, 2018

According to AP reports, Attorney General Jeff Sessions has rescinding the Cole Memo, which was the Obama administration's protection of state-compliant cannabis businesses that allowed for the legal cannabis industry to flourish across the country.

Med-X, Inc. leads cannabis industry in banning pesticides for truly organic weed
March 31, 2016

Med-X, Inc. has identified the use of Nature-Cide All Purpose Insecticide, its licensed, all-natural pesticide for the advanced cultivation of cannabis. Med-X, Inc. co-founder and chief operating officer, Matthew Mills, in a Criticl article, explains the advantages of their breakthrough invention.

Med-X, Inc. Resumes Equity Crowdfunding, Allows Ordinary Americans To Invest In The Cannabis Industry
October 3, 2017

Medical cannabis-focused Med-X, Inc. has resumed its Regulation A+ (Reg A+) equity crowdfunding campaign that stems from the Jobs Act of 2012. New regulations allowing regular Americans to invest in what was once reserved for only the wealthy, is now moving to Main Street.

Inside the Cannabis Industry’s First Attempt at Equity Crowdfunding
January 15, 2016

Med-X was officially founded in 2014, but co-founders Matthew Mills and Dr. David Toomey, along with Med-X board member Dr. Allan Kurtz, had been networking together since 1999, and the idea for Med-X had begun percolating as early as 2011. Explains COO Mills, “We decided when this sector started to

Med-X Enters Into Merger & Acquisition Agreement With Pacific Shore Holdings
December 23, 2017

Med-X, Inc. (Med-X) and Pacific Shore Holdings, Inc. (PSH) announced on Friday they have entered into a definitive merger and acquisition agreement. According to the Agreement, Med-X, an ancillary cannabis company and a leader in cannabis media and cultivation services arena, will combine with PSH,

Med-X, Inc. Returns to Crowdfunding Via the StartEngine Crowdfunding Portal
September 28, 2017

LOS ANGELES, Sept. 28, 2017 /PRNewswire/ -- Med-X, Inc. (Med-X) With all regulatory matters resolved in its favor, Med-X, Inc. is pleased to announce a return to Regulation A+ equity crowdfunding via the StartEngine platform.

Med-X Inc.'s Nature-Cide Insecticide Moves into Cannabis Cultivation Supply
April 4, 2016

LOS ANGELES, April 4, 2016 /PRNewswire/ -- Med-X, Inc. announced today that its Nature-Cide products are beginning to generate revenue ahead of the company's original revenue schedule due to industry demand. Med-X, Inc. has struck a deal with cultivation distribution venue GrowMinded to supply Natur

Med-X, Inc. Enters into Merger Acquisition Agreement Capturing Multiple Revenue Streams
December 22, 2017

Med-X, Inc. ("Med-X") and Pacific Shore Holdings, Inc. ("PSH") today announced that they have entered into a definitive merger and acquisition agreement ("Agreement"). Via the Agreement, Med-X, an ancillary cannabis company and a leader in cannabis media and cultivation services arena, will combine

Startup Med-X, Inc.‘s specialty insecticide is paving its way to becoming a leading player in the emerging $5.4 billion cannabis industry
March 23, 2016

Med-X, an LA-based enterprise that launched in 2014, has cannabis cultivators flocking to its all-natural insecticide, Nature-Cide All Purpose, for its effectiveness in killing everything from whiteflies to spider mites.

MedX’s Matthew Mills Discusses The Booming Cannabis Industry In America with Bruce Buffer
March 11, 2016

On this week’s “IT’S TIME!” show Buffer’s guest is none other than Mills and Buffer, who is the Founder of MED-X, Inc., as well as the COO, which is a company that is taking advantage of the booming Marijuana industry in the United States at full force with products that offer effective nontoxic an

Going Green Again
August 11, 2016

Pennsylvanian Greg Pettis, a 23-year-veteran of the pest control industry, is an advocate of green pesticides. But that wasn’t always so.

Med-X, Inc. Completes Merger Acquisition Agreement Capturing Multiple Revenue Streams
April 18, 2018

Med-X, Inc. ("Med-X") and Pacific Shore Holdings, Inc. ("PSH") today announced that they have completed the merger and acquisition agreement ("Agreement") announced in December 2017. Via the Agreement, Med-X, an ancillary cannabis company and a leader in cannabis media and the cultivation services

Med-X, Inc. Engages NMS Capital Advisors as Its Exclusive Investment Banking Advisor
March 26, 2018

NMS Capital Advisors, LLC ("NMS"), a leading global focused investment banking and asset management firm, announced today that it has been engaged by Med-X, Inc. ("Med-X"). NMS will be Med-X's exclusive financial advisor and investment bank, providing financial, strategic, and M&A advisory, and inve

Help your kids get through flu season with these thermal stuffed animals
January 21, 2018

These clever stuffed animals can be heated in the microwave or cooled in the freezer to make a hot compress or provide cold relief for inflammation. Each pack comes with two animals, and the options are adorable: rabbits, bears, elephants, koalas, monkeys, and hippos are all available to satisfy

Thermal-Aid Zoo Goes Viral with Reviews, Giveaways and Consumer Demand
February 8, 2013

The Thermal-Aid Zoo is a 100% natural therapeutic, cuddly heating/cooling plush animal, specifically designed for kids, to reduce swelling, ease pain and gives kids of all ages a huggable pal year round.

Residex Professional Pest Control Distribution Signs for National Placement of Nature-Cide Products
March 17, 2016

Pacific Shore Holdings, Inc. today announced that it has taken the first steps towards national pest control distribution of its Nature-Cide products by signing a Distribution Agreement with Residex, LLC. Residex who has a national footprint in the United States with 25 distribution centers in 14 st

Med-X, Inc. and Nature-Cide Sign Leading Pest Control Company Pestmaster Services to Direct Distribution Deal
September 24, 2018

"We have been focused on using safe practices since 1979," said Van Diepen. "Nature-Cide is exactly the kind of product line our customers demand that we use. We have tested these products for months and the results are there. We have a shared culture and mission to reduce risk in our communities. T

Nature-Cide Offers New Granular Product
September 25, 2018

Nature-Cide Granular is an all-natural granular insect control for turf, lawns, bedding, exterior perimeters and additional listed locations designed to kill and deter crawling insects, including emerging larvae, while repelling rodents (including voles) and reptiles.

Thermal-Aid Zoo Releases a Miniature Collectable Version of its Popular Heating and Cooling Pack for Kids
August 8, 2013

Pacific Shore Holdings, Inc. (PSHR) introduces the New Thermal-Aid Zoo Animal "Mini's". The Thermal-Aid Zoo are a 100% natural therapeutic, cuddly heating/cooling plush animal, specifically designed for kids, to reduce swelling, ease pain and gives kids of all ages a huggable pal year round. Now you

Pacific Shore Holdings launch therapeutic, plush heating/cooling toys for kids
August 9, 2013

Pacific Shore Holdings, Inc., introduced the new Thermal-Aid Zoo animal "Mini’s". The Thermal-Aid Zoo animals are a 100% natural therapeutic, heating/cooling plush animals specifically designed for kids, to reduce swelling, ease pain and give kids of all ages a "huggable" pal year round, the company

Pacific Shore Holdings, Inc. Moves Headquarters to a 20% Larger Location in Los Angeles
October 13, 2015

Pacific Shore Holdings, Inc. (PSHR) has relocated its corporate office three miles away from its former address in Chatsworth to a 20% larger building in Canoga Park, California. The new 30,000 square foot facility is located at 8236 Remmet Ave. Canoga Park, CA 91304. The move is in response to com

Nature-Cide, a Division of Pacific Shore Holdings, Inc. to Launch New Products and Labeling at National Hardware Show in Las Vegas, NV
May 5, 2014

Pacific Shore Holdings, Inc's. (OTCBB:PSHR), Nature-Cide Division, a pest management service company that's also engaged in the manufacturing of all-natural and eco-friendly pesticides, is excited to announce that they will be attending the National Hardware Convention in Las Vegas, NV, May 6 throug

Nature-Cide Granular Insecticide
August 17, 2018

Nature-Cide Granular Insecticide is labeled for tick control, as well as for several other crawling pests and emerging larvae. The water-activated formula, which has 25(b)-exempt status, can be applied in the rain. It also can be added to fertilizer for a one-pass application on golf courses, turf,

Getting in on the Ground Floor of Cannabis Investment
December 4, 2018

This brings us to Med-X, a green technology manufacturing company that has spent the past decade developing multiple successful verticals in the mainstream health and cannabis sectors, including all-natural, environmentally conscious products for pest control, aromatherapy, pain management, and cann

Med-X, Inc. Qualified by the SEC to Launch Second Crowdfunding Offering in Conjunction with Investment Banking Firm NMS Capital Advisors, LLC.
August 15, 2019

On August 12, 2019, the Securities Exchange Commission (SEC) qualified Med-X, Inc. (Med-X) to begin the company's second Regulation A+ Equity Crowdfunding Offering. This time Med-X will be working with a Broker/Dealer, NMS Capital Advisors, LLC ("NMS Capital"), in selling the offering which is now l

Updates

Med-X, Inc. Surpasses 2018 Revenue During the 4th Quarter of 2019 While in Final Stages of it’s First Pest Control Service Acquisition

13 days ago

In this update, Matthew reports on how 2019 revenues have already surpassed 2018 revenues across multiple divisions as well as how its potential acquisition could lead to engagements with large scale investors. This progress has motivated Med-X Management to prepare the company accordingly, as they meet with the potential sponsors to list the company. 



CLICK HERE TO WATCH VIDEO


Our largest Over The Counter or “OTC”  Pharmacy distributor Cardinal Health / RGH just placed an order to continue to distribute the Thermal-Aid product line throughout “OTC” pharmacies which are performing well and selling-through. We anticipate these orders to continue to increase in frequency and volume. 

This kind of traction coupled with our direct to consumer boost through Amazon, is forcing us to quickly ramp up our production for this line as PO’s from our distributors continue to get larger and inventory requirements from Amazon Fulfillment continue to increase and seemingly are snowballing. We need to be ready for 2020 because at these rates it is going to be a busy start to the year. 

We feel strongly that with all of this increased visibility and with these high sell-through rates it is only a matter of time before the bigger “OTC” retail players jump on board and begin to load the products as well, so we need to be ready!

Conversations have also continued to ramp up with many overseas pest control operation distributors. We are in talks with companies from Canada, Mexico, Indonesia, Nicaragua, Brazil, Peru, Australia, Saudi Arabia, Dubai, Bahrain, South Africa, United Kingdom, New Zealand, Malaysia, the Philippines, and South Korea. Governments in these countries continue to tighten regulations on the use of pesticides and these distributors are scrambling to get new products in place that will pass their toxicity and environmental impact requirements. 

The importation of pesticides into foreign countries requires the company to comply with each countries stringent regulatory red tape. We are working to have the Nature-Cide products fully scrutinized and registered in all of these countries. Once the studies are done we will be able to register our products on an individual basis with each country, all of which have their own requirements and processes that require the above-mentioned testing to be completed. This is an incredibly important time for our company to buckle down and invest as much of our resources as possible in getting the Nature-Cide products positioned accordingly. Once this is accomplished, Nature-Cide products and protocols could very well end up leading the all-natural global pest control markets.  

The company is also in the final stages of an acquisition of a pest control service company that is doing over $1M annually in service revenue. 

With this acquisition, our plan is to significantly increase revenue in 2020 compared to 2019 starting in Q1. We are all hopeful and waiting patiently for the legal teams to finalize agreements, so the company can make the acquisition official.  We are also hopeful that several other acquisition targets will fall into line once the first transaction is complete, and word continues to spread that we are actively acquiring like-minded pest control companies. 

The revenue growth and acquisition plans have various large scale investment funds watching the company very closely, and we are excited to have the opportunity to present our work accordingly. This said we are meeting with an interested sponsor in the coming days to discuss the process of a 15c2-11 filing which is the first step in the potential listing of the company. The goal is to organize and engage with the perfect financial partner to support our growth and acquisition plans, then expand further if and when we list in a public marketplace.   

The team is dedicated to working harder than ever in the final weeks of 2019, in order to make sure the company continues to grow and we begin 2020 in the best shape we have ever been in. We are all excited to see what the future holds.

Matthew is available to discuss the growth of the company one-on-one, so don't hesitate to reach out and schedule an appointment. 


Thank you for all of your continued support. 


Nick Phillips

Med-X Team


DISCLAIMER AND FORWARD-LOOKING STATEMENTS 

The securities offered by Med-X, Inc. hereby are highly speculative. Investing in shares of MED-X, INC. involves significant risk. This investment is suitable only for persons who can afford to lose their entire investment. Furthermore, investors must understand that an investment could be illiquid for an indefinite period of time. No public market currently exists for the securities and if and when a public market develops following this offering it may not continue. You should read the NEW Offering Circular as well as all Securities Exchange Commission filings before making any investment in the Company. 

This release may contain forward-looking statements regarding projected business performance, operating results, financial condition and other aspects of the company, expressed by such language as "expected," "anticipated," "projected" and "forecasted." Please be advised that such statements are estimates only and there is no assurance that the results stated or implied by forward-looking statements will actually be realized by the company. Forward-looking statements may be based on management assumptions that prove to be wrong. The company and its business are subject to substantial risks and potential events beyond its control that would cause material differences between predicted results and actual results, including the company incurring operating losses and experiencing unexpected material adverse events.


Nature-Cide Shines at PestWorld 2019

about 1 month ago

In this update, COO, Matthew Mills reports from the TradeShow floor at PestWorld 2019.


CLICK HERE TO WATCH VIDEO


At the show, the team has been meeting with hundreds of business owners who are all interested in learning more about adding green options to their product offerings. Owners of pest control companies from all over the world have all met in one place to get educated and to network. “We have been doing this show for a few years now and this year is by far the most attention we have had around the company,” says Matthew Mills. “When we first started doing this a few years ago people would come up to us and not recognize the need for green pest control products, as well as believing that Nature-Cide couldn’t possibly be a viable solution. Now the word has spread and people from all over the country and the world are waiting in line to talk to us. The market is changing really fast. Those same people are coming back to learn more because their customers are asking for green options. We are in a really great place,” says Matthew. 

The show is known worldwide as the premier pest control tradeshow and with that comes numerous face to face meetings with international companies that we typically don’t get much face time with. Today, Matthew met with several large scale pest control company owners who want the Nature-Cide products in their countries. He met with leadership from companies in several strong and emerging markets but more significant and important were the meetings with companies in Malaysia, Brazil, and Korea as we have been in communication with them for weeks. It is always very nice to put faces to names. We walked away with some very positive takeaways and solid commitments to work together with multiple international regulatory bodies to get the Nature-Cide products registered for usage within the various countries.

We had multiple investment banking groups who have had their eyes on us and decided to come down and see the attention we were generating first hand. These groups are going to continue to dig in as it appears that they like the company’s positioning, especially on the Nature-Cide front. The continued hope is we find more institutional partners who are trying to diversify by investing in environmentally friendly companies.  

Matthew had several important meetings with the leadership teams from our Distribution partners at Target-Specialty Products and Univar. It is critical that these relationships continue not only to be beneficial to all parties but to also flourish in 2020. The distributors have again given us their word that they will continue to push our products as one of the top-performing effective natural product lines. These multi-billion-dollar businesses see the green wave coming and they want to be a part of it.   

We also locked down some commitments on the retail side of things. We cannot fully disclose all the details yet, but we are hopeful that this relationship will be very fruitful. So stay tuned for that announcement in the coming weeks. 

This truly is a very exciting time for Med-X, Inc. We have a solid position in several markets with proprietary products and solutions that have a great upside in markets that need new life. 

Without each and every investor’s focus, we could not continue to grow. We appreciate all of your support. 

If you want to speak directly with Matthew and hear more about the events that took place at the show, please reach out to our investor relations department so we can put something on the books. If you do not have a point of contact yet, please let us know and someone will follow up accordingly. 


Nick Phillips

Med-X Team


DISCLAIMER AND FORWARD-LOOKING STATEMENTS 

The securities offered by Med-X, Inc. hereby are highly speculative. Investing in shares of MED-X, INC. involves significant risk. This investment is suitable only for persons who can afford to lose their entire investment. Furthermore, investors must understand that an investment could be illiquid for an indefinite period of time. No public market currently exists for the securities and if and when a public market develops following this offering it may not continue. You should read the NEW Offering Circular as well as all Securities Exchange Commission filings before making any investment in the Company. 


This release may contain forward-looking statements regarding projected business performance, operating results, financial condition and other aspects of the company, expressed by such language as "expected," "anticipated," "projected" and "forecasted." Please be advised that such statements are estimates only and there is no assurance that the results stated or implied by forward-looking statements will actually be realized by the company. Forward-looking statements may be based on management assumptions that prove to be wrong. The company and its business are subject to substantial risks and potential events beyond its control that would cause material differences between predicted results and actual results, including the company incurring operating losses and experiencing unexpected material adverse events.

Nature-Cide Cannabis Cultivation Customers Should All Test Negative for the Harmful Chemicals Potentially Causing the Recent National Public Health Crisis

about 1 month ago

In this Update, COO, Matthew Mills, talks about how the Nature-Cide team and The Marijuana Times team have been warning and covering the potential for a serious national crisis involving Cannabis laced with dangerous pesticides for over the past three years.

CLICK HERE FOR VIDEO


Although the current situation is sad and scary, it does not come as a surprise to anyone here at Med-X, Inc. If you are unaware of the developments, it has been confirmed by the CDC that illegal cannabis vape cartridges are the leading culprit for the 12 deaths and over 800 hospitalized. Investigations are on-going and are proving that nearly all black market cannabis extracts contain dangerous levels of Myclobutanil, a synthetic chemical when burned turns into Hydrogen Cyanide. This is one of many chemicals legal and illegal growers use to remediate pests in commercial cannabis grows. Matthew warns that the media is only reporting part of the problem, as smoking cannabis that has been treated with the same toxic chemicals, can still emit poisonous gases when smoking cannabis flower. 

All Nature-Cide customers who use Nature-Cide in their facilities to grow organic cannabis should all test negative and all products should be deemed safe for consumption by regulators. The Marijuana Times has been covering this since 2016 and also broke a story in June of this year which reported on a massive illegal outlaw operation in Mendocino County where the Sheriff randomly tested the confiscated products and the results were astounding. 

https://www.marijuanatimes.org/pesticides-in-illegal-pot-a-budding-health-crisis/

Two months later, people started getting sick and dying. Our advice to everyone is please, don’t consume Cannabis unless you buy it from a legal dispensary or you grow it yourself. 

Matthew also invites any interested investors to join him and the Nature-Cide team as they travel to San Diego, California next week for PestWorld 2019. Matthew has some big meetings with large operators in the US, South Korea, Malaysia, Australia, the Middle East and more. This is a great opportunity to talk to our customers and distributors as well as really see for yourself how fast this brand is growing domestically and internationally. 

We are prepped and ready for the best trade show the company has ever had. This is a very exciting time and Matthew looks forward to sharing it with anyone who wants to attend. 

We appreciate all of you for your continued support as we enter the fourth quarter and are working towards some strong initiatives, that we hope will prove to be our best year ever. 


Nick Phillips

Med-X, Inc.


DISCLAIMER AND FORWARD-LOOKING STATEMENTS 

The securities offered by Med-X, Inc. hereby are highly speculative. Investing in shares of MED-X, INC. involves significant risk. This investment is suitable only for persons who can afford to lose their entire investment. Furthermore, investors must understand that an investment could be illiquid for an indefinite period of time. No public market currently exists for the securities and if and when a public market develops following this offering it may not continue. You should read the NEW Offering Circular as well as all Securities Exchange Commission filings before making any investment in the Company. 


This release may contain forward-looking statements regarding projected business performance, operating results, financial condition and other aspects of the company, expressed by such language as "expected," "anticipated," "projected" and "forecasted." Please be advised that such statements are estimates only and there is no assurance that the results stated or implied by forward-looking statements will actually be realized by the company. Forward-looking statements may be based on management assumptions that prove to be wrong. The company and its business are subject to substantial risks and potential events beyond its control that would cause material differences between predicted results and actual results, including the company incurring operating losses and experiencing unexpected material adverse events.


Thermal-Aid Brand Gears Up for Another Busy Fourth Quarter

about 2 months ago

In this update, COO, Matthew Mills, takes us out of the boardroom and into the Med-X, Inc. facility once again to review our Thermal-Aid brand, and cover new developments as we enter the brand's historically best time of year, the fourth quarter. 


CLICK HERE TO WATCH VIDEO


Currently, Thermal-Aid products hold nationwide retail positions in retailers like;

Ralphs Supermarket Pharmacy

King Soopers Supermarket Pharmacy 

City Market Supermarket Pharmacy 

Kroger (East Coast) Supermarket Pharmacy 

Approximately 1,500 Independent Pharmacies in various regions around the country.


These accounts are all serviced by Cardinal Health and RGH Distribution. These positions take years to obtain and we feel fortunate to continue our customer growth, due to year over year sell-through. 

On the direct to the consumer side, all of the Thermal-Aid products are sold directly to the consumer via our own ecommerce platform - thermalaidproducts.com.

You can also buy the products directly from the largest Flexible Spending Account retailer, FSAstore.com. All these products are approved for FSA sales as well as insurance approved so Doctors can cover the cost of the product through medical insurance reimbursement when they provide these to their patients when in their offices. 

The newest development for the Thermal-Aid brand is a new Partnership with a reputable marketing agency with a proven track record for optimizing Amazon seller strategies. As of this week, we have re-worked all of our brand product listings and have gone through the rigorous process of preparing all of our Thermal-Aid products to be Fulfilled by Amazon (“FBA”). This will give our products Prime Status, the Amazon badge and the ability to ship these products the same day and even with Prime Now within hours depending on the location of the customer. In conjunction with our planned Amazon marketing initiatives, we feel strongly that this is what is going to put us on another level from a direct to consumer retail position. The first wave of FBA inventory is being processed now by Amazon and we should know more in the coming weeks.

These initiatives have been in the making for months now, and we hope to close out 2019 with a solid push, work out the kinks and hit the ground running at full steam going into 2020. 

If you or a family member suffers from Migraine Headaches, arthritis pain or any other condition or you have kids and want to get a sample of the products to let us know by sending us an email and someone will follow up accordingly to make that happen. 


Sample Product Inquiries: info@medx-rx.com 


Thanks for your continued support. 


DISCLAIMER AND FORWARD-LOOKING STATEMENTS 

The securities offered by Med-X, Inc. hereby are highly speculative. Investing in shares of MED-X, INC. involves significant risk. This investment is suitable only for persons who can afford to lose their entire investment. Furthermore, investors must understand that an investment could be illiquid for an indefinite period of time. No public market currently exists for the securities and if and when a public market develops following this offering it may not continue. You should read the NEW Offering Circular as well as all Securities Exchange Commission filings before making any investment in the Company. 


This release may contain forward-looking statements regarding projected business performance, operating results, financial condition and other aspects of the company, expressed by such language as "expected," "anticipated," "projected" and "forecasted." Please be advised that such statements are estimates only and there is no assurance that the results stated or implied by forward-looking statements will actually be realized by the company. Forward-looking statements may be based on management assumptions that prove to be wrong. The company and its business are subject to substantial risks and potential events beyond its control that would cause material differences between predicted results and actual results, including the company incurring operating losses and experiencing unexpected material adverse events.

Strict International Regulations on Pesticides Continue to Fuel Nature-Cide Expansion and Growth Outlook

about 2 months ago

In this update, COO, Matthew Mills takes you inside the Med-X facility for a look at the day's preparations for several existing customers and a few new international Natura-Cide orders. The international interest in Nature-Cide is a clear indicator of the growing trend of the professional pesticide industry moving to include safer green options. 


CLICK HERE TO VIEW VIDEO


The team is making final preparations for what we hope to be our most important and successful appearance at the largest pest control trade show in the world, PestWorld 2019. This year’s trade show is taking place in San Diego from October 15th to October 18th. If you want to meet with Matthew Mills and see the action for yourself let us know so we can make arrangements in advance for your visit. Our distributors are all excited to showcase the Nature-Cide brand and we would love the opportunity for any shareholder to actually see the excitement around Nature-Cide in the broad scope of the international community. 


Matthew and the management team is also focused on providing updates more frequently as we move forward. Our commitment to providing reliable communications to our shareholders is critical. Expect a few more very important updates coming down the pipeline in the next couple of weeks leading up to Pestworld and post trade show.


Thanks for your continued support, 


Nick Phillips

Med-X, Inc.


DISCLAIMER AND FORWARD-LOOKING STATEMENTS 

The securities offered by Med-X, Inc. hereby are highly speculative. Investing in shares of MED-X, INC. involves significant risk. This investment is suitable only for persons who can afford to lose their entire investment. Furthermore, investors must understand that an investment could be illiquid for an indefinite period of time. No public market currently exists for the securities and if and when a public market develops following this offering it may not continue. You should read the NEW Offering Circular as well as all Securities Exchange Commission filings before making any investment in the Company. 


This release may contain forward-looking statements regarding projected business performance, operating results, financial condition and other aspects of the company, expressed by such language as "expected," "anticipated," "projected" and "forecasted." Please be advised that such statements are estimates only and there is no assurance that the results stated or implied by forward-looking statements will actually be realized by the company. Forward-looking statements may be based on management assumptions that prove to be wrong. The company and its business are subject to substantial risks and potential events beyond its control that would cause material differences between predicted results and actual results, including the company incurring operating losses and experiencing unexpected material adverse events.

Med-X, Inc. Qualified by the SEC to Launch Second Crowdfunding Offering in Conjunction with Investment Banking Firm NMS Capital Advisors, LLC

3 months ago

In this video update, COO, Matthew Mills, discusses the companies going forward strategy for raising capital with our investment banking partner, NMS Capital Advisors. He reveals a new version of the Malibu Brands Pacific Pain Relief Cream and also discusses the companies strategy to increase revenue via acquisitions to position the company to list on a national exchange like the Nasdaq. 

The press release can also be seen in its entirety below.


Click Here to Watch Video



Link to Press Release

LOS ANGELES, Aug. 15, 2019 /PRNewswire/ -- Med-X, Inc. -- On August 12, 2019, the Securities Exchange Commission (SEC) qualified Med-X, Inc. (Med-X) to begin the company's second Regulation A+ Equity Crowdfunding Offering. This time Med-X will be working with a Broker/Dealer, NMS Capital Advisors, LLC ("NMS Capital"), in selling the offering which is now live on the crowdfunding portal StartEngine.com. The company plans to also link and use its own web site resources which include, Med-X, Inc. the official company website, as well as placing links and information regarding the company's offering on its divisional and subsidiary web properties, such as Thermal-Aid, Nature-Cide, The National Investor Network, Malibu Brands and The Marijuana Times.

"Regulation A+ allows us to advertise and reach out to all investors, not just wealthy accredited investors who comprise the top few percents of the country. While we do have a large number of the wealthy accredited investors, it is our philosophy to let all of our customers who use our products and or services, our small business partners, friends, family and fans to all participate in our company mission," explained Med-X President and COO, Matthew Mills.

For this offering, while allowing the "Working Class American" to buy Med-X shares for as little as $420 for 525 shares, Med-X management and NMS Capital are working together to create a syndicated network of Broker/Dealers to accelerate the offering. This will provide Med-X with the ability to execute on immediate key growth strategies. 

For example, Med-X is in the midst of discussions and negotiations with multiple like-minded Eco-friendly pest control service companies, for strategic acquisition and or partnerships within the Nature-Cide's Service Division. This strategy is expected to fast-track the use of Nature-Cide's environmentally friendly and effective products within residential and wide-spread commercial applications nationwide. Other growth opportunities for Med-X divisions include adding new products to Nature-Cide's product line up, while expanding Malibu Brands new Pacific Pain Relief Cream to include a legal hemp CBD infused formulation version of the product, along with Thermal Aid's product lines and the Media Divisions, which includes the Marijuana Times and the new National Investor Network.

ABOUT MED-X, INC. 

Med-X, Inc. is a Nevada corporation formed in February 2014 to support the fast-paced environmentally friendly green scene products and services sectors, with its Nature-Cide, Malibu Brands and Thermal-Aid divisions as well as the emerging hemp and cannabis industry through such activities as compound identification and extraction of the identified cannabidiol (CBD) compounds for the present medical industry demand. The company's digital magazine, The Marijuana Times, publishes high quality media content for the medical cannabis community to potentially generate revenue from advertisers as well as sell industry related merchandise to consumers. For more information regarding Med-X, Inc., please visit www.medx-rx.com, email info@medx-rx.com or call 818-349-2870.

DISCLAIMER AND FORWARD-LOOKING STATEMENTS 

The securities offered by Med-X, Inc. hereby are highly speculative. Investing in shares of MED-X, INC. involves significant risk. This investment is suitable only for persons who can afford to lose their entire investment. Furthermore, investors must understand that an investment could be illiquid for an indefinite period of time. No public market currently exists for the securities and if and when a public market develops following this offering it may not continue. You should read the NEW Offering Circular as well as all Securities Exchange Commission filings before making any investment in the Company. 

This release may contain forward-looking statements regarding projected business performance, operating results, financial condition and other aspects of the company, expressed by such language as "expected," "anticipated," "projected" and "forecasted." Please be advised that such statements are estimates only and there is no assurance that the results stated or implied by forward-looking statements will actually be realized by the company. Forward-looking statements may be based on management assumptions that prove to be wrong. The company and its business are subject to substantial risks and potential events beyond its control that would cause material differences between predicted results and actual results, including the company incurring operating losses and experiencing unexpected material adverse events.

Show More Updates End of Updates